Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Sep 12;111(37):607-14.
doi: 10.3238/arztebl.2014.0607.

Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice

Affiliations
Randomized Controlled Trial

Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice

Stefan Viktor Vormfelde et al. Dtsch Arztebl Int. .

Abstract

Background: Orally anticoagulated patients with insufficient knowledge about their treatment have a higher risk of complications. Standardized patient education could raise their level of knowledge and improve time spent within target INR range.

Methods: This cluster randomized trial included 319 anticoagulated patients drawn from 22 general medical practices. 185 patients received patient education, conducted by practice nurses, consisting of a video, a brochure, and a questionnaire; 134 control patients received only the brochure. The primary endpoint was knowledge about treatment six months after the patient education session. The secondary endpoints were time in the INR (international normalized ratio) target range and complications of anticoagulation.

Results: Patients in the intervention and control groups were of comparable mean age (73 vs. 72 years). They answered a comparable number of questions correctly before the intervention (6.8 ± 0.2 vs. 6.7 ± 0.2) but differed significantly on this measure at six months (9.9 ± 0.2 vs. 7.6 ± 0.2, mean difference 2.3 questions, 95% confidence interval [CI] 1.5-3.1, p< 0.001). In the six months prior to the intervention, the INR was in the target range 65 ± 2% vs. 66 ± 3% of the time; in the six months afterward, 71 ± 1% vs. 64 ± 3% of the time (mean difference 7 percentage points, 95% CI -2 to -16 percentage points, p = 0.11). The complication rates were comparable in the two groups (12% vs. 16%, p = 0.30). Patients in the intervention group approved of patient education sessions to a greater extent than control patients (87% vs. 56%).

Conclusion: Patient education was found to be practical, to improve knowledge relating to patient safety in a durable manner, and to meet with the approval of the patients who received it. There was a statistically non-significant trend toward an improvement of the time spent in the INR target range. In view of the major knowledge deficits of orally anticoagulated patients, standardized patient education ought to be made a part of their routine care.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT recruitment flowchart (31);INR, international normalized ratio
Figure 2
Figure 2
The effect of patient education on knowledge, and, in turn, on anticoagulation Means and standard errors of the following variables before and after patient education are shown: a) 13-point knowledge score; b) time spent in INR target range; c) partial scores on the patient‘s individual situation (up to 5 points), INR-related knowledge (up to 4 points), and practical knowledge (up to 4 points). INR, international normalized ratio.
Figure 3
Figure 3
Differences of mean values between intervention arms with respect to the primary endpoint, with covariate adjustment, and the related 95% confidence intervals for the various subgroups. The p-values corresponded to the hypothesis that no interaction was present

Comment in

References

    1. Schwabe U, Paffrath D. Berlin, Heidelberg: Springer Medizin Verlag; 2012. Arzneiverordnungsreport 2012.
    1. You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e531S–e575S. - PMC - PubMed
    1. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e419S–e494S. - PMC - PubMed
    1. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719–2747. - PubMed
    1. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur J Cardiothorac Surg. 2012;42:S1–44. - PubMed

Publication types

MeSH terms

Associated data